Craft

Maxigen Biotech

Revenue

NT$811.6 M

FY, 2025

Maxigen Biotech Summary

Company Summary

Overview
Maxigen Biotech (MBI) is a company that develops, manufactures, and markets biomedical and skincare products. It offers bone void fillers, intra-articular injections, dental grafts, ophthalmic viscoelastic devices, face masks, toner, sunscreen lotions, and more.
Type
Public
Status
Active
Founded
1998
HQ
TW | view all locations
Website
https://mbi.com.tw
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Taoyuan City HQ

    Taiwan

    No. 88, Keji 1st Road, Guishan District

Maxigen Biotech Financials

Summary Financials

Revenue (Q1, 2026)
NT$190.9M
Gross profit (Q1, 2026)
NT$146.7M
Net income (Q1, 2026)
NT$52.8M
Cash (Q1, 2026)
NT$649.5M
EBIT (Q1, 2026)
NT$61.1M

Footer menu